サマリー

世界の多発性骨髄腫治療薬市場 2023-2027
Technavioは多発性骨髄腫治療薬市場を監視しており、2023年から2027年にかけて6419.94万ドル、予測期間中にCAGR5.9％で加速して成長すると予測しています。当レポートでは、多発性骨髄腫治療薬市場の全体分析、市場規模・予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、多発性骨髄腫の罹患率の増加、生物学的療法に対する需要の増加、強力な採用率によって牽引されています。
Technavioの多発性骨髄腫治療薬市場は、以下のように区分されています。
治療法の展望別
- 標的療法
- 生物学的治療
- 化学療法
- その他
販売チャネル別
- 病院薬局
- 小売店
- Eファーマシー
地域別
- 北米
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、ナノメディシンプラットフォームの出現が、今後数年間の多発性骨髄腫治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、マイクロ治療薬の出現と発展途上国の急速な成長の可能性は、市場の大きな需要につながるでしょう。
Technavio社は、主要パラメータの分析を通じて、複数のソースからのデータの調査、合成、総括を行うことで、市場の詳細な姿を提示します。多発性骨髄腫治療薬市場に関する当レポートの対象領域は以下の通りです。
- 多発性骨髄腫治療薬市場のサイジング
- 多発性骨髄腫治療薬市場の予測
- 多発性骨髄腫治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Abbott Laboratories、AbbVie Inc、Amgen Inc、AstraZeneca Plc、Bristol Myers Squibb Co、Cipla Ltd、第一三共Inc.ホフマン・ラ・ロシュ社、フレゼニウス社、グラクソ・スミスクライン社、アムジェン社、アストラゼネカ社、ブリストル・マイヤーズスクイブ社、シプラ社、第一三共社、イーライ・リリー社、F．KGaA、グラクソ・スミスクライン・ピーエルシー、ジョンソン・アンド・ジョンソン、Merck and Co.Inc.、Novartis AG、Pfizer Inc.、PharmaMar SA、Sanofi SA、Takeda Pharmaceutical Co.Ltd.、Teva Pharmaceutical Industries Ltd.）が含まれています。また、多発性骨髄腫治療薬の市場分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/multiple-myeloma-drugs-market-analysis をご覧ください。
Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数のソースからのデータの調査、合成、総括により、市場の詳細な姿を提示します。業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global multiple myeloma drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global multiple myeloma drugs market 2017 - 2021 ($ million)
o 4.2 Therapy Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Therapy
o 6.1 Market segments
o Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
o 6.2 Comparison by Therapy
o Exhibit 32: Chart on Comparison by Therapy
o Exhibit 33: Data Table on Comparison by Therapy
o 6.3 Targeted therapy - Market size and forecast 2022-2027
o Exhibit 34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
o 6.4 Biologic therapy - Market size and forecast 2022-2027
o Exhibit 38: Chart on Biologic therapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Biologic therapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Biologic therapy - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Biologic therapy - Year-over-year growth 2022-2027 (%)
o 6.5 Chemotherapy - Market size and forecast 2022-2027
o Exhibit 42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
o 6.6 Others - Market size and forecast 2022-2027
o Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Therapy
o Exhibit 50: Market opportunity by Therapy ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 51: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 52: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 53: Chart on Comparison by Distribution Channel
o Exhibit 54: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacy - Market size and forecast 2022-2027
o Exhibit 55: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
o 7.4 Retail pharmacy - Market size and forecast 2022-2027
o Exhibit 59: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
o 7.5 E-pharmacy - Market size and forecast 2022-2027
o Exhibit 63: Chart on E-pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on E-pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on E-pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on E-pharmacy - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 67: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 71: Chart on Geographic comparison
o Exhibit 72: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 105: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 116: Abbott Laboratories - Overview
o Exhibit 117: Abbott Laboratories - Business segments
o Exhibit 118: Abbott Laboratories - Key news
o Exhibit 119: Abbott Laboratories - Key offerings
o Exhibit 120: Abbott Laboratories - Segment focus
o 12.4 AbbVie Inc.
o Exhibit 121: AbbVie Inc. - Overview
o Exhibit 122: AbbVie Inc. - Product / Service
o Exhibit 123: AbbVie Inc. - Key offerings
o 12.5 Amgen Inc.
o Exhibit 124: Amgen Inc. - Overview
o Exhibit 125: Amgen Inc. - Product / Service
o Exhibit 126: Amgen Inc. - Key offerings
o 12.6 Bristol Myers Squibb Co.
o Exhibit 127: Bristol Myers Squibb Co. - Overview
o Exhibit 128: Bristol Myers Squibb Co. - Product / Service
o Exhibit 129: Bristol Myers Squibb Co. - Key offerings
o 12.7 Daiichi Sankyo Co. Ltd.
o Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 131: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 134: Daiichi Sankyo Co. Ltd. - Segment focus
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 GlaxoSmithKline Plc
o Exhibit 140: GlaxoSmithKline Plc - Overview
o Exhibit 141: GlaxoSmithKline Plc - Business segments
o Exhibit 142: GlaxoSmithKline Plc - Key offerings
o Exhibit 143: GlaxoSmithKline Plc - Segment focus
o 12.10 Johnson and Johnson
o Exhibit 144: Johnson and Johnson - Overview
o Exhibit 145: Johnson and Johnson - Business segments
o Exhibit 146: Johnson and Johnson - Key news
o Exhibit 147: Johnson and Johnson - Key offerings
o Exhibit 148: Johnson and Johnson - Segment focus
o 12.11 Merck and Co. Inc.
o Exhibit 149: Merck and Co. Inc. - Overview
o Exhibit 150: Merck and Co. Inc. - Business segments
o Exhibit 151: Merck and Co. Inc. - Key news
o Exhibit 152: Merck and Co. Inc. - Key offerings
o Exhibit 153: Merck and Co. Inc. - Segment focus
o 12.12 Novartis AG
o Exhibit 154: Novartis AG - Overview
o Exhibit 155: Novartis AG - Business segments
o Exhibit 156: Novartis AG - Key offerings
o Exhibit 157: Novartis AG - Segment focus
o 12.13 Pfizer Inc.
o Exhibit 158: Pfizer Inc. - Overview
o Exhibit 159: Pfizer Inc. - Product / Service
o Exhibit 160: Pfizer Inc. - Key news
o Exhibit 161: Pfizer Inc. - Key offerings
o 12.14 PharmaMar SA
o Exhibit 162: PharmaMar SA - Overview
o Exhibit 163: PharmaMar SA - Business segments
o Exhibit 164: PharmaMar SA - Key news
o Exhibit 165: PharmaMar SA - Key offerings
o Exhibit 166: PharmaMar SA - Segment focus
o 12.15 Sanofi SA
o Exhibit 167: Sanofi SA - Overview
o Exhibit 168: Sanofi SA - Business segments
o Exhibit 169: Sanofi SA - Key news
o Exhibit 170: Sanofi SA - Key offerings
o Exhibit 171: Sanofi SA - Segment focus
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 176: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 177: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 178: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 179: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 180: Teva Pharmaceutical Industries Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 181: Inclusions checklist
o Exhibit 182: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 183: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 184: Research methodology
o Exhibit 185: Validation techniques employed for market sizing
o Exhibit 186: Information sources
o 13.5 List of abbreviations
o Exhibit 187: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global multiple myeloma drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Biologic therapy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Biologic therapy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Biologic therapy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Biologic therapy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Therapy ($ million)
Exhibits51: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits52: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by Distribution Channel
Exhibits54: Data Table on Comparison by Distribution Channel
Exhibits55: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on E-pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on E-pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on E-pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on E-pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Distribution Channel ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Abbott Laboratories - Overview
Exhibits117: Abbott Laboratories - Business segments
Exhibits118: Abbott Laboratories - Key news
Exhibits119: Abbott Laboratories - Key offerings
Exhibits120: Abbott Laboratories - Segment focus
Exhibits121: AbbVie Inc. - Overview
Exhibits122: AbbVie Inc. - Product / Service
Exhibits123: AbbVie Inc. - Key offerings
Exhibits124: Amgen Inc. - Overview
Exhibits125: Amgen Inc. - Product / Service
Exhibits126: Amgen Inc. - Key offerings
Exhibits127: Bristol Myers Squibb Co. - Overview
Exhibits128: Bristol Myers Squibb Co. - Product / Service
Exhibits129: Bristol Myers Squibb Co. - Key offerings
Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits131: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits134: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits135: F. Hoffmann La Roche Ltd. - Overview
Exhibits136: F. Hoffmann La Roche Ltd. - Business segments
Exhibits137: F. Hoffmann La Roche Ltd. - Key news
Exhibits138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits140: GlaxoSmithKline Plc - Overview
Exhibits141: GlaxoSmithKline Plc - Business segments
Exhibits142: GlaxoSmithKline Plc - Key offerings
Exhibits143: GlaxoSmithKline Plc - Segment focus
Exhibits144: Johnson and Johnson - Overview
Exhibits145: Johnson and Johnson - Business segments
Exhibits146: Johnson and Johnson - Key news
Exhibits147: Johnson and Johnson - Key offerings
Exhibits148: Johnson and Johnson - Segment focus
Exhibits149: Merck and Co. Inc. - Overview
Exhibits150: Merck and Co. Inc. - Business segments
Exhibits151: Merck and Co. Inc. - Key news
Exhibits152: Merck and Co. Inc. - Key offerings
Exhibits153: Merck and Co. Inc. - Segment focus
Exhibits154: Novartis AG - Overview
Exhibits155: Novartis AG - Business segments
Exhibits156: Novartis AG - Key offerings
Exhibits157: Novartis AG - Segment focus
Exhibits158: Pfizer Inc. - Overview
Exhibits159: Pfizer Inc. - Product / Service
Exhibits160: Pfizer Inc. - Key news
Exhibits161: Pfizer Inc. - Key offerings
Exhibits162: PharmaMar SA - Overview
Exhibits163: PharmaMar SA - Business segments
Exhibits164: PharmaMar SA - Key news
Exhibits165: PharmaMar SA - Key offerings
Exhibits166: PharmaMar SA - Segment focus
Exhibits167: Sanofi SA - Overview
Exhibits168: Sanofi SA - Business segments
Exhibits169: Sanofi SA - Key news
Exhibits170: Sanofi SA - Key offerings
Exhibits171: Sanofi SA - Segment focus
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits175: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits176: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits177: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits178: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits179: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits180: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Information sources
Exhibits187: List of abbreviations